|
Day 1
Vendor Session -
Proteomics Technologies & Applications
Reproducible Removal Of Multiple High-Abundant Proteins From Human
Serum
With Polyclonal Antibody-Based LC Affinity Column
Kelly Zhang, Nina Zolotarjova, Gordon Nicol, James Martosella,
Liang-Sheng Yang, Cory Szafranski, Jerome Bailey, and Barry
Boyes
Agilent Technologies
It is believed that the analysis of serum proteome will provide access
to new protein markers that may hold the information needed to
revolutionize disease diagnosis and therapeutic monitoring. However,
the masking effect of a few well-characterized, high-abundant proteins
in serum has been a major obstacle for the detection of low-abundant
proteins that may be of interest for biomarker identification. The
Agilent Multiple Affinity Removal System combines the specificity of
antibody-antigen recognition and the efficiency of standard LC
instrumentation. For the first time, a ready-to-use high-abundant
protein removal kit containing an affinity column and optimized mobile
phases (Buffers A and B) is available for simultaneous removal of
multiple proteins from human serum in a single step. The column removes
albumin, transferrin, IgG, IgA, haptoglobin and antitrypsin with high
specificity and reproducibility. The buffers are optimized to minimize
removal of proteins not targeted by the antibodies. As a result, the
less-abundant proteins can be resolved with improved visibility using
current separation methodologies such as 1DGE, 2DGE and LC systems.

Return to Proceedings »
|